Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Bluebird Bio, Inc. (BLUE)  
$1.02 0.04 (3.77%) as of 4:30 Mon 5/13


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 139,126,000
Market Cap: 141.91(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.8871 - $4.83
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ss-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 17,438 35,533 57,514 116,582
Total Sell Value $26,639 $61,294 $139,194 $443,003
Total People Sold 3 5 5 9
Total Sell Transactions 3 9 12 23
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 939
  Page 13 of 38  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Davidson David Chief Medical Officer   •       –      –    2019-02-01 4 A $0.00 $0 D/D 9,375 31,616     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-02-01 4 A $0.00 $0 D/D 6,750 33,592     -
   Cole Jason Chief Legal Officer   •       –      –    2019-02-01 4 A $0.00 $0 D/D 6,250 26,444     -
   Wentworth Kory James Principal Accounting Officer   •       –      –    2019-02-01 4 A $0.00 $0 D/D 2,500 6,954     -
   Walsh Jeffrey T. Chief Financialand Strategy Of   •       –      –    2019-02-01 4 A $0.00 $0 D/D 8,438 40,921     -
   Finger Alison Cecily Chief Commercial Officer   •       –      –    2019-02-01 4 A $0.00 $0 D/D 5,000 19,681     -
   Wentworth Kory James Principal Accounting Officer   •       –      –    2019-01-28 4 AS $125.96 $26,326 D/D (209) 4,403     -
   Davidson David Chief Medical Officer   •       –      –    2019-01-18 4 AS $130.05 $264,644 D/D (2,035) 22,241     -
   Davidson David Chief Medical Officer   •       –      –    2019-01-18 4 OE $24.47 $49,796 D/D 2,035 24,276     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-01-16 4 AS $124.25 $236,069 D/D (1,900) 26,842     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-01-16 4 OE $75.60 $105,840 D/D 1,400 28,742     -
   Walsh Jeffrey T. Chief Financialand Strategy Of   •       –      –    2019-01-16 4 AS $125.14 $375,428 D/D (3,000) 32,483     -
   Walsh Jeffrey T. Chief Financialand Strategy Of   •       –      –    2019-01-16 4 OE $24.47 $73,410 D/D 3,000 35,483     -
   Finger Alison Cecily Chief Commercial Officer   •       –      –    2019-01-07 4 S $113.29 $73,068 D/D (643) 14,548     -
   Davidson David Chief Medical Officer   •       –      –    2019-01-07 4 S $113.29 $302,734 D/D (2,664) 22,241     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-01-07 4 AS $107.41 $436,363 D/D (3,879) 27,342     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2019-01-07 4 OE $50.51 $30,306 D/D 600 31,221     -
   Leschly Nick President and CEO   •       •      –    2019-01-07 4 S $113.29 $837,966 D/D (7,374) 193,203     -
   Walsh Jeffrey T. Chief Financialand Strategy Of   •       –      –    2019-01-07 4 S $113.29 $342,276 D/D (3,012) 32,483     -
   Cole Jason Chief Legal Officer   •       –      –    2019-01-07 4 S $113.29 $160,914 D/D (1,416) 20,194     -
   Finger Alison Cecily Chief Commercial Officer   •       –      –    2019-01-03 4/A S $98.32 $47,273 D/D (476) 15,191     -
   Finger Alison Cecily Chief Commercial Officer   •       –      –    2019-01-03 4 S $98.31 $42,506 D/D (428) 15,239     -
   Davidson David Chief Medical Officer   •       –      –    2019-01-03 4 AS $100.32 $10,032 D/D (100) 24,905     -
   Davidson David Chief Medical Officer   •       –      –    2019-01-03 4 OE $24.47 $2,447 D/D 100 25,005     -
   Davidson David Chief Medical Officer   •       –      –    2019-01-02 4 AS $96.35 $741,028 D/D (7,500) 24,905     -
  939 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 13 of 38
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us